SCHEMBL6500883

SCHEMBL6500883

CC(Cl)C(=O)NC1=C(N(C)C)C(=O)c2ccccc2C1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.48
HTT P42858 7/20 0.48
LMNA P02545 6/20 0.48
L3MBTL1 Q9Y468 4/20 0.48
NOD2 Q9HC29 1/20 0.48
HSP90AA1 P07900 5/20 0.45
HSP90AB1 P08238 5/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
RAB9A P51151 5/20 0.45
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
APAF1 O14727 2/20 0.45
CASP3 P42574 2/20 0.45
SENP8 Q96LD8 2/20 0.45
SENP7 Q9BQF6 2/20 0.45
SENP6 Q9GZR1 2/20 0.45
GAA P10253 2/20 0.45
NPC1 O15118 2/20 0.45
MAPT P10636 7/20 0.44
KDM4E B2RXH2 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6502899 0.86 ALDH1A1 (0.47) ALDH1A1HTTLMNAL3MBTL1NOD2
SCHEMBL6509320 0.81 TDP2 (0.49) ALDH1A1HTTLMNAL3MBTL1NOD2
SCHEMBL6500778 0.76 ALDH1A1 (0.44) ALDH1A1HTTLMNAL3MBTL1NOD2
SCHEMBL31171425 0.76 MEN1 (0.55) ALDH1A1HTTLMNAL3MBTL1SMN1; SMN2
SCHEMBL6365874 0.73 L3MBTL1 (0.53) L3MBTL1HSP90AA1HSP90AB1SMN1; SMN2RAB9A
SCHEMBL29967684 0.72 HKDC1 (0.51) ALDH1A1HTTLMNAL3MBTL1SMN1; SMN2
SCHEMBL6366669 0.69 MAOA (0.62) ALDH1A1L3MBTL1SMN1; SMN2RAB9AMEN1
SCHEMBL134428 0.68 HSP90AA1 (0.68) ALDH1A1HTTLMNAL3MBTL1HSP90AA1
SCHEMBL31162649 0.68 HSP90AA1 (0.68) ALDH1A1HTTLMNAL3MBTL1HSP90AA1
SCHEMBL8102448 0.68 HSP90AA1 (0.47) ALDH1A1HTTLMNAL3MBTL1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032794-A1 Diamine derivatives of quinone and uses thereof CLINICAL DATA, INC. 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032794-A1 Diamine derivatives of quinone and uses thereof NQO1, DPYD, NQO2 ALDH1A1 128/4885HTT 3519/4885LMNA 3778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.